Fred Ramsdell
Fondateur chez Sonoma Biotherapeutics, Inc.
Profil
Fred Ramsdell is the founder of Sonoma Biotherapeutics, Inc. founded in 2019, where he holds the title of Chief Scientific Officer.
In 2014-2016, he worked as Vice President-Immunology at aTyr Pharma, Inc. Dr. Ramsdell holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California San Diego.
Postes actifs de Fred Ramsdell
| Sociétés | Poste | Début |
|---|---|---|
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Fondateur | 01/01/2019 |
Anciens postes connus de Fred Ramsdell
| Sociétés | Poste | Fin |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/12/2016 |
Formation de Fred Ramsdell
| University of California, Los Angeles | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |